Level Four Advisory Services LLC grew its position in shares of Danaher Co. (NYSE:DHR – Free Report) by 3.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,683 shares of the conglomerate’s stock after purchasing an additional 58 shares during the quarter. Level Four Advisory Services LLC’s holdings in Danaher were worth $386,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Howard Capital Management Group LLC boosted its holdings in shares of Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after acquiring an additional 48 shares during the period. CreativeOne Wealth LLC boosted its stake in Danaher by 24.7% during the 3rd quarter. CreativeOne Wealth LLC now owns 1,542 shares of the conglomerate’s stock worth $429,000 after purchasing an additional 305 shares during the period. Edgestream Partners L.P. grew its position in Danaher by 466.1% during the 3rd quarter. Edgestream Partners L.P. now owns 10,965 shares of the conglomerate’s stock worth $3,048,000 after purchasing an additional 9,028 shares during the last quarter. Erste Asset Management GmbH acquired a new position in Danaher in the third quarter valued at $5,988,000. Finally, FSA Wealth Management LLC purchased a new stake in shares of Danaher in the third quarter valued at about $50,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Insider Activity at Danaher
In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is owned by insiders.
Analyst Ratings Changes
Read Our Latest Stock Analysis on Danaher
Danaher Stock Down 0.4 %
Shares of NYSE DHR opened at $205.01 on Tuesday. The firm has a market cap of $146.52 billion, a P/E ratio of 38.83, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The firm’s 50 day moving average price is $213.91 and its 200 day moving average price is $235.91.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the company earned $2.09 earnings per share. As a group, sell-side analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.32 dividend. The ex-dividend date is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. Danaher’s dividend payout ratio (DPR) is currently 24.24%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
- Five stocks we like better than Danaher
- Short Selling: How to Short a Stock
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Using the MarketBeat Stock Split Calculator
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- With Risk Tolerance, One Size Does Not Fit All
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.